Pradaxa (dabigatran etexilate)

pCPA File Number: 20784
Negotiation Status:
Concluded with an LOI
Indication(s):
Atrial fibrillation prevention of stroke and systemic embolism
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd. Ltee.
CADTH Project Number:
S0214
pCPA Engagement Letter Issued:
Negotiation Process Concluded: